Chloramine-T in high-specific-activity radioiodination of antibodies using N-succinimidyl-3-(trimethylstannyl)benzoate as an intermediate

Bolton, 1973, The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylation agent, Biochem. J., 133, 529, 10.1042/bj1330529 Ferens, 1984, High level of iodination of monoclonal antibody fragments for radiotherapy, J. Nucl. Med., 25, 367 Freaker, 1978, Protein and cell membrane iodinations with a sparingly soluble chloramide, Biochem. Biophys. Res. Commun., 880, 849, 10.1016/0006-291X(78)91322-0 Garg, 1989, Synthesis of radioiodinated N-succinimidyl iodobenzoate, Int. J. Radiat. Appl. Instrum. Part A, 40, 485, 10.1016/0883-2889(89)90131-7 Garg, 1993, N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate, Nucl. Med. Biol., 20, 379, 10.1016/0969-8051(93)90067-5 Greenwood, 1963, The preparation of 131I-labelled human growth hormone of high specific radioactivity, Biochem. J., 89, 114, 10.1042/bj0890114 Johansson, 1991, Tumour-growth suppression in nude mice by murine monoclonal antibody Factors hampering successful therapy, Int. J. Cancer, 48, 297, 10.1002/ijc.2910480224 Larsen, 1994, Preparation and quality control of 211At-labelled and 125I-labelled monoclonal antibodies, J. Label. Compd. Radiopharm., 34, 773, 10.1002/jlcr.2580340811 Lindmo, 1984, Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess, J. Immunol. Methods, 72, 77, 10.1016/0022-1759(84)90435-6 Mantovani, 1990, Evaluation of the immunoreactive fraction of an anti-tumour monoclonal antibody, Br. J. Cancer, 62, 1517 Matzku, 1987, Iodination of monoclonal IgG antibodies at sub-stoichiometric level, Nucl. Med. Biol., 14, 451 Milius, 1986, Organoastatine chemistry, Appl. Radiat. Isot., 37, 799, 10.1016/0883-2889(86)90274-1 Miotti, 1992, Membrane association and shedding of the GPI-anchored Ca-MOv18 antigen in human ovary carcinoma cells, Int. J. Cancer, 51, 499, 10.1002/ijc.2910510326 Miotti, 1987, Characterisation of human ovarian carcinoma associated antigens by novel monoclonal antibodies with tumour-restricted specificity, Int. J. Cancer, 39, 297, 10.1002/ijc.2910390306 Vaughan, 1978, The preparation of astatine-labeled proteins using an electrophilic reaction, Int. J. Nucl. Med. Biol., 5, 229, 10.1016/0047-0740(78)90145-6 Wilbur, 1989, Development of a stable radioiodinating agent to label monoclonal antibodies for radiotherapy of cancer, J. Nucl. Med., 30, 216 Zalutsky, 1989, Labeling of monoclonal antibodies and F(ab′)2 fragments with the α-particle-emiting nuclid At-211, Proc. Natl. Acad. Sci. USA, 86, 7149, 10.1073/pnas.86.18.7149 Zalutsky, 1987, A Method for radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine, Appl. Radiat. Isot., 38, 1051, 10.1016/0883-2889(87)90069-4 Zalutsky, 1988, Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl) benzoate Intermediate, Cancer Res, 48, 1446 Zalutsky, 1989, Enhanced tumour uptake and in vivo stability of a monoclonal antibody using N-succinimidyl 3-(trimethyl-n-butylstannyl)benzoate, Cancer Res, 49, 5543